165 related articles for article (PubMed ID: 15724061)
1. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.
Kataoka H; Takahashi S; Takase K; Yamasaki S; Yokosuka T; Koike T; Saito T
Int Immunol; 2005 Apr; 17(4):421-7. PubMed ID: 15724061
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.
Tang Q; Boden EK; Henriksen KJ; Bour-Jordan H; Bi M; Bluestone JA
Eur J Immunol; 2004 Nov; 34(11):2996-3005. PubMed ID: 15468055
[TBL] [Abstract][Full Text] [Related]
3. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
[TBL] [Abstract][Full Text] [Related]
4. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
5. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.
Birebent B; Lorho R; Lechartier H; de Guibert S; Alizadeh M; Vu N; Beauplet A; Robillard N; Semana G
Eur J Immunol; 2004 Dec; 34(12):3485-96. PubMed ID: 15484187
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
7. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
8. Impaired regulatory T cell function in germ-free mice.
Ostman S; Rask C; Wold AE; Hultkrantz S; Telemo E
Eur J Immunol; 2006 Sep; 36(9):2336-46. PubMed ID: 16897813
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
10. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
11. Thymic regulatory T cells.
Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
[TBL] [Abstract][Full Text] [Related]
12. Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.
Gorczynski RM; Lee L; Boudakov I
Transplantation; 2005 Feb; 79(4):488-91. PubMed ID: 15729177
[TBL] [Abstract][Full Text] [Related]
13. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
14. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
17. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
Chen X; Oppenheim JJ; Howard OM
J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
[TBL] [Abstract][Full Text] [Related]
18. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
19. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
Nishikawa H; Kato T; Tawara I; Saito K; Ikeda H; Kuribayashi K; Allen PM; Schreiber RD; Sakaguchi S; Old LJ; Shiku H
J Exp Med; 2005 Mar; 201(5):681-6. PubMed ID: 15753203
[TBL] [Abstract][Full Text] [Related]
20. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
